HAI2024 Book - Flipbook - Page 5
46 Establishing the
interchangeability between CSF and
PET for identifying patients with
Alzheimer's disease pathology who
are suitable for amyloid targeting
therapies ..................................... 205
Lopresti, Brian........................................... 207
47 Exploring A-T+ within the AT(N)
framework ...................................207
Wang, Yi-Ting ............................................208
48 Sex-specific synergistic
interaction between Aβ and p-tau
predicts faster tangle accumulation
in females .................................... 208
Wang, Jian ................................................ 212
49 Comparison of visual
interpretation and quantitation in
detecting amyloid pathology using
florbetapir F-18 PET imaging:
Results from nuclear medicine
physicians or radiologists practicing
at community healthcare settings
...................................................... 212
Seto, Mabel................................................ 216
50 Parental history of memory
impairment predicts β-amyloid
burden and positivity in a preclinical
population .................................... 216
Ossenkoppele, Rik ......................................217
51 A head-to-head comparison
between plasma p-tau217 and tauPET for predicting future cognitive
decline among cognitively
unimpaired individuals ................. 217
Bilgel, Murat ..............................................220
52 Comparison of amyloid PET and
plasma biomarkers in predicting
future memory decline among
cognitively normal individuals .... 220
Gatto, Rodolfo ........................................... 223
53 Confocal microscopy
assessment of flortaucipir binding
by a fluorescence analog compound
T726 shows 4RT overlap in
frontotemporal lobar degeneration
..................................................... 223
HAI2024 - 5
Gatto, Rodolfo ...........................................224
54 Correlative Histopathological
evaluation of basal ganglia iron
deposition and tau and PiB PET in
Alzheimer’s disease and
frontotemporal lobar degeneration
..................................................... 224
An, Zhaoqi ................................................. 226
55 Unraveling Alzheimer's disease
heterogeneity: a comparative
analysis using HYDRA AND CHIMERA
..................................................... 226
McKay, Nicole ............................................ 229
56 Prevalence of Alzheimer’s
disease pathology in studies of
memory and aging ....................... 229
Talmasov, Daniel ....................................... 231
57 Depression in amyloid-positive
individuals is associated with a
faster rate of tau accumulation on
longitudinal positron-emission
tomography .................................. 231
Kim, Min-Jeong ......................................... 232
58 Chronic neuroinflammation in
older adults with persistent Long
COVID: the preliminary findings of
[18F]FEPPA PET imaging ............ 232
Hanseeuw, Bernard ................................... 233
59 PET staging of tauopathy using
amygdala ......................................233
Vokali, Efthymia ........................................ 236
60 Discovery and optimization of
[18F]ACI-15916, a promising PET
tracer for the diagnosis of
Parkinson’s disease and other asynucleinopathies ........................236
Collij, Lyduine ............................................ 237
61 Clinical relevance of visually
positive amyloid-PET burden in the
occipital lobe ................................ 237
Collij, Lyduine ............................................ 239
62 Tau-PET subtypes show distinct
profiles of cerebrospinal fluid
biomarkers, neurodegeneration, and